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examined the role ofAPC (monocytes and B ceils) in presentation 
of Asp to T ceils by comparing proliferative responses of APC- 
depleted and non-depleted samples. Mthough proliferation was 
greater in the presence of APe, depleted samples howed signifi- 
cant proliferation (SI 2-30) indicating that Asp directly stimulates 
T cell proliferation. These results how a moderately strong CD4 
and CD8 T cell response to Asp that shows some TCR V]3 
restriction. The T cell proliferative response to Asp appears to be 
partly mediated by a non-classical APC-independent pathway. 
These findings should facilitate the generation of Asp-specific T
ceils for adoptive immunotherapy. 
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Transplantation f G-CSF-mobilized PBSC is associated with 
less acute GVtlD (aGVHD) and improving engraftment despite 
much larger numbers of T ceils in unmanipulated PBSC prepara- 
tions than in bone marrow grafts. As urvival of the graft is depend- 
ent on the Thl /Th2 cytokine balance, we measured the syntheses 
of Th l  (IL-2, TNF-alpha, and IFN-gamma) and Th2 (IL-10) 
cytokines by CD4+ and CDS+ T ceils in vitro following activation 
with phorbol ester (PMA) and Staphylococcus enterotoxin B (SEB) 
at 2, 4, 6, and 8 weeks, post-transplantation andanalyzed the cells 
syuthesizing cytokines by 4-color flow cytomett T. Typically, the 
number of CDS+ T cells that synthesized TNF-alpha, IFN- 
gamma, and IL-2 following activation with PMA and SEB steadily 
increased with engraftment. The number of CD4+ T ceils that 
were activated with PMA also steadily increased with engraftment; 
however, the number of SEB-activated CD4+ T ceils that synthe- 
sized IL-2 peaked at 4 weeks, post-transplantation and declined 
thereafter. By comparison, the number of CD4+ and CD8+ T cells 
that syuthesized IL-10 in response to activation by PMA and SEB 
peaked at 4 weeks and declined precipitously by week 8, post-trans- 
plantation. Since only one patient developed GVHD that resolved 
during the monitoring period, the increased syntheses of Th l  
cytoldnes by activated CD4+ and CD8+ T cells after engraftment 
and at a time when G-CSF maintenance was no longer provided is 
indicative of the immune competence of the engrafted cells and 
their propensity for producing Thl  cytokines upon activation, an 
event hat could potentially lead to the development of GVI ID. 
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RAPID RECONSTITUTION OF SERUM ANTI-PRP ANTIBODY LEVELS IN 
RECIPIENTS OF ALLOGENEIC MARROW TRANSPLANTATION 
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As immediate survival of the transplant recipients improves, pre- 
vention of early and Iate post-transplant infectious c mplications 
plays a major role in long-term outcome. Timely re-immunization 
for pediatric stem cell transplant (HSCT) recipients may prevent 
devastating complications of vaccine-preventable diseases. 
Immune responses to polysaccharide vaccines (H. influcnzae type 
b, pneumococcal nd meningococcal) have been suboptimal early 
post-transplant. Polyribosyl-ribitol phosphate (PRP) is an essen- 
tial componcnt of bacterial capsular polysaccharides, such as of 
Streptococcus pneumoniae or Hemophilus influenzae. Natural 
antibodies to the polysaccharides develop as a result of the anti- 
genic crossreactivity with E.coli strains. To evaluate the time and 
pattern of anti-PRP titers in pediatric patients after allogeneic 
related HSCT 7 patients were evaluated 6-12 months post- BMT. 
Two patients had a history of acute graft versus host disease, how- 
ever all patients were off immunosuppression at the time of evalu- 
ation. Titers were measured by enzyme-linked immunosorbent 
assay (ELISA) at Children's Hospital Los Angeles; CA. Serum 
anti-PRP titers varied from 16 to 900 pg/ml, median 117pg/ml. 
Anti-PRP titers were higher (200-900 pg/ml, mean 900 pg/ml) in 
patients with non-malignant diseases compared to patients with 
malignancies (16-228, mean 48 pg/ml). There were no significant 
correlation with the T and B ceil counts and T cell function. Non- 
protective anti-PRP levels (less than i00 pg/ml) at 1 year after 
I tSCT were observed in two AML patients. In one low anti-PRP 
titers were associated with non-detectable anti-tetanus, anti-diph- 
theria antibody titers and low B cell count. In this study we 
observe rapid reconstitution of the serum anti-PRP titers in 5 of 7 
recipients of allogeneic BMT. Currently we are studying the pre- 
dictability of serum anti-PRP ievels with regard to functional 
responses to vaccination post-BMT. 
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ANTI-CD3 STIMULATED T REGULATORY CELLS DO NOT INHIBIT 
SYNGENEIC BONE MARROW PROGENITOR CELL PROLIFERATION 
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CD4+CD25 * T (T reg) cells with regulatory function are being 
considered for use to control GVHD and support successful allo- 
geneic bone marrow transplantation. T reg cells are present in the 
spleen and bone marrow and have been reported to produce 
cytokines including TGF]3. Since encounter with antigen post 
BMT can activate Treg populations, the presence of such ceils in 
recipient lymphohelnatopoietic conapartments raises the possibili- 
ty that TGF{3 or other cytokines could affect progenitor cell activ- 
ity. Low density (LD) B6 bone marrow cells (Sxl03/well) were 
supplemented with rmIL3 to induce proliferative responses in 72 
hour cultures. Highly enriched Treg populations were then pro- 
duced fi'om spleen and lymph nodes of B6 (H-219 mice. When 
added to cultures containing purified syngeneic CD4+CD25 - T 
cells (SxlOVwell), syngeneic accessory cells (Sxl0~/well) and anti- 
CD3 nLAb (15%), the Treg cells (1:1) effectively inhibited (>70%) 
the proliferative response by the CD4+CD25- responding cells. To 
examine the ability, of T reg cells to regnlate BMC proliferation, 
CD4+CD25 + T ceils were cultured with LD BMC and syngeneic 
accessory cells in the presence of anti-CD3 nzAb. At high (10:1) 
Treg : LD BMC numbers, the BMC proliferative responses were 
not inhibited. In summary, the present i71 vitro findings support 
the notion that activation of CD4+CD25 + T reg cells during BMT 
will not interfere with t e proliferative activity of transplanted or
host progenitor populations. Interestingly, when both 
CD4+CD25 T cells and LD BMC were cultured together with 
Treg cells in the presence of IL-3 and anti-CD3, strong prolifera- 
tive responses were detected in these cultures. These findings raise 
the possibility that CD4*CD25 + regulatory cells do not inhibit 
proliferative responses in the presence of IL3 and BMC. Experi- 
ments are currently examining if T reg ceils fail to suppress the 
response of the CD4+CD25 T cells in these cultures. 
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SEX STEROID ABLATION BY CASTRATION ENHANCES HAEMOPOI- 
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"['here is a general decline in immune function with age. This 
process, which involves thymic atrophy, is known to be reversed 
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